Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

HMG-CoA reductase inhibitors (statin) prevents retinal neovascularization in a model of oxygen-induced retinopathy.

Bartoli M, Al-Shabrawey M, Labazi M, Behzadian MA, Istanboli M, El-Remessy AB, Caldwell RW, Marcus DM, Caldwell RB.

Invest Ophthalmol Vis Sci. 2009 Oct;50(10):4934-40. doi: 10.1167/iovs.08-2158. Epub 2008 Dec 20.

2.

Trans-Chalcone prevents VEGF expression and retinal neovascularization in the ischemic retina.

Lamoke F, Labazi M, Montemari A, Parisi G, Varano M, Bartoli M.

Exp Eye Res. 2011 Oct;93(4):350-4. doi: 10.1016/j.exer.2011.02.007. Epub 2011 Feb 24.

PMID:
21354136
3.

Aldose reductase deficiency reduced vascular changes in neonatal mouse retina in oxygen-induced retinopathy.

Fu ZJ, Li SY, Kociok N, Wong D, Chung SK, Lo AC.

Invest Ophthalmol Vis Sci. 2012 Aug 20;53(9):5698-712. doi: 10.1167/iovs.12-10122.

PMID:
22836764
4.

Role of the adrenergic system in a mouse model of oxygen-induced retinopathy: antiangiogenic effects of beta-adrenoreceptor blockade.

Ristori C, Filippi L, Dal Monte M, Martini D, Cammalleri M, Fortunato P, la Marca G, Fiorini P, Bagnoli P.

Invest Ophthalmol Vis Sci. 2011 Jan 5;52(1):155-70. doi: 10.1167/iovs.10-5536.

PMID:
20739470
5.

Suppression of retinal neovascularization by shRNA targeting HIF-1alpha.

Xia XB, Xiong SQ, Xu HZ, Jiang J, Li Y.

Curr Eye Res. 2008 Oct;33(10):892-902. doi: 10.1080/02713680802416670.

PMID:
18853324
6.

Reduced retinal neovascularization, vascular permeability, and apoptosis in ischemic retinopathy in the absence of prolyl hydroxylase-1 due to the prevention of hyperoxia-induced vascular obliteration.

Huang H, Van de Veire S, Dalal M, Parlier R, Semba RD, Carmeliet P, Vinores SA.

Invest Ophthalmol Vis Sci. 2011 Sep 29;52(10):7565-73. doi: 10.1167/iovs.11-8002.

7.

Inhibition of oxygen-induced retinopathy in RTP801-deficient mice.

Brafman A, Mett I, Shafir M, Gottlieb H, Damari G, Gozlan-Kelner S, Vishnevskia-Dai V, Skaliter R, Einat P, Faerman A, Feinstein E, Shoshani T.

Invest Ophthalmol Vis Sci. 2004 Oct;45(10):3796-805.

PMID:
15452091
8.

Beta-adrenoreceptor agonism influences retinal responses to hypoxia in a model of retinopathy of prematurity.

Dal Monte M, Martini D, Latina V, Pavan B, Filippi L, Bagnoli P.

Invest Ophthalmol Vis Sci. 2012 Apr 24;53(4):2181-92. doi: 10.1167/iovs.11-9408.

PMID:
22410551
9.

Inhibition of NAD(P)H oxidase activity blocks vascular endothelial growth factor overexpression and neovascularization during ischemic retinopathy.

Al-Shabrawey M, Bartoli M, El-Remessy AB, Platt DH, Matragoon S, Behzadian MA, Caldwell RW, Caldwell RB.

Am J Pathol. 2005 Aug;167(2):599-607.

10.

Localization of VEGF receptor-2 (KDR/Flk-1) and effects of blocking it in oxygen-induced retinopathy.

McLeod DS, Taomoto M, Cao J, Zhu Z, Witte L, Lutty GA.

Invest Ophthalmol Vis Sci. 2002 Feb;43(2):474-82.

PMID:
11818393
11.

ICAM-1 depletion does not alter retinal vascular development in a model of oxygen-mediated neovascularization.

Kociok N, Radetzky S, Krohne TU, Gavranic C, Liang Y, Semkova I, Joussen AM.

Exp Eye Res. 2009 Oct;89(4):503-10. doi: 10.1016/j.exer.2009.05.005. Epub 2009 May 29.

PMID:
19482023
12.

Role of NADPH oxidase and Stat3 in statin-mediated protection against diabetic retinopathy.

Al-Shabrawey M, Bartoli M, El-Remessy AB, Ma G, Matragoon S, Lemtalsi T, Caldwell RW, Caldwell RB.

Invest Ophthalmol Vis Sci. 2008 Jul;49(7):3231-8. doi: 10.1167/iovs.08-1754. Epub 2008 Mar 31.

14.

Ischaemia-induced retinal neovascularisation and diabetic retinopathy in mice with conditional knockout of hypoxia-inducible factor-1 in retinal Müller cells.

Lin M, Chen Y, Jin J, Hu Y, Zhou KK, Zhu M, Le YZ, Ge J, Johnson RS, Ma JX.

Diabetologia. 2011 Jun;54(6):1554-66. doi: 10.1007/s00125-011-2081-0. Epub 2011 Mar 1.

PMID:
21360191
15.

Contrasting effect of estrogen on VEGF induction under different oxygen status and its role in murine ROP.

Miyamoto N, Mandai M, Takagi H, Suzuma I, Suzuma K, Koyama S, Otani A, Oh H, Honda Y.

Invest Ophthalmol Vis Sci. 2002 Jun;43(6):2007-14.

PMID:
12037012
16.

Celecoxib attenuates retinal angiogenesis in a mouse model of oxygen-induced retinopathy.

Liu N, Chen L, Cai N.

Int J Clin Exp Pathol. 2015 May 1;8(5):4990-8. eCollection 2015.

17.

Up-regulation of VEGF by retinoic acid during hyperoxia prevents retinal neovascularization and retinopathy.

Wang L, Shi P, Xu Z, Li J, Xie Y, Mitton K, Drenser K, Yan Q.

Invest Ophthalmol Vis Sci. 2014 May 27;55(7):4276-87. doi: 10.1167/iovs.14-14170.

PMID:
24867581
18.

TWEAK/Fn14 pathway is a novel mediator of retinal neovascularization.

Ameri H, Liu H, Liu R, Ha Y, Paulucci-Holthauzen AA, Hu S, Motamedi M, Godley BF, Tilton RG, Zhang W.

Invest Ophthalmol Vis Sci. 2014 Feb 10;55(2):801-13. doi: 10.1167/iovs.13-12812.

19.

Deguelin inhibits retinal neovascularization by down-regulation of HIF-1alpha in oxygen-induced retinopathy.

Kim JH, Kim JH, Yu YS, Shin JY, Lee HY, Kim KW.

J Cell Mol Med. 2008 Dec;12(6A):2407-15. doi: 10.1111/j.1582-4934.2008.00243.x.

20.

Triamcinolone reduces neovascularization, capillary density and IGF-1 receptor phosphorylation in a model of oxygen-induced retinopathy.

Hartnett ME, Martiniuk DJ, Saito Y, Geisen P, Peterson LJ, McColm JR.

Invest Ophthalmol Vis Sci. 2006 Nov;47(11):4975-82.

Items per page

Supplemental Content

Write to the Help Desk